Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Failure to Request FDA Approval

On October 11, 2002 the FDA submitted a letter to Amerisource Health Services Corporation, a subsidiary of AmerisourceBergen, in reference to the firm’s marketing of Humibid LA Tablets. The FDA had recently approved a similar drug; however, Amerisource had not received approval for Humibid. Marketing this new drug without FDA approval violated the Federal Food, Drug, and Cosmetic Act and required Amerisource to bring its marketing efforts into compliance with the act.

Misconduct Type
Health
Enforcement Agency
Health and Human Services
Contracting Party
None
Court Type
Administrative
Disposition
Administrative Agreement
Date of Violation Notification
10/11/2002
Contractors Involved Penalty
Total
AmerisourceBergen $0
Further Information Released
FDA Warning Letter 8/25/2006

Federal Contractor Misconduct Database